HSBC Holdings’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-47,132
| Closed | -$725K | – | 2994 |
|
|
2025
Q4 | $725K | Buy |
+47,132
| New | +$519K | ﹤0.01% | 2117 |
|
|
2025
Q2 | – | Sell |
-19,560
| Closed | -$254K | – | 3074 |
|
|
2025
Q1 | $254K | Buy |
19,560
+607
| +3% | +$8.03K | ﹤0.01% | 2482 |
|
|
2024
Q4 | $244K | Buy |
18,953
+4,859
| +34% | +$58.8K | ﹤0.01% | 2608 |
|
|
2024
Q3 | $158K | Sell |
14,094
-3,634
| -20% | -$40.1K | ﹤0.01% | 2695 |
|
|
2024
Q2 | $200K | Sell |
17,728
-83
| -0.5% | -$966 | ﹤0.01% | 2555 |
|
|
2024
Q1 | $221K | Buy |
+17,811
| New | +$232K | ﹤0.01% | 2629 |
|
|
2023
Q1 | – | Sell |
-42,973
| Closed | -$450K | – | 2770 |
|
|
2022
Q4 | $450K | Buy |
42,973
+20,661
| +93% | +$240K | ﹤0.01% | 2332 |
|
|
2022
Q3 | $236K | Sell |
22,312
-8,513
| -28% | -$111K | ﹤0.01% | 2539 |
|
|
2022
Q2 | $393K | Buy |
30,825
+20,791
| +207% | +$221K | ﹤0.01% | 2477 |
|
|
2022
Q1 | $111K | Sell |
10,034
-4,754
| -32% | -$57.7K | ﹤0.01% | 3105 |
|
|
2021
Q4 | $207K | Buy |
+14,788
| New | +$243K | ﹤0.01% | 3017 |
|
|
2021
Q1 | – | Sell |
-15,079
| Closed | -$69K | – | 2819 |
|
|
2020
Q4 | $69K | Buy |
+15,079
| New | +$68.3K | ﹤0.01% | 2971 |
|
|
2019
Q4 | – | Sell |
-18,046
| Closed | -$65K | – | 3073 |
|
|
2019
Q3 | $65K | Buy |
+18,046
| New | +$70K | ﹤0.01% | 3010 |
|
Other funds holding DVAX
HSBC Holdings's DVAX Position: Q1 2026 in Review
HSBC Holdings sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 47,132 shares — an estimated $725K sold.
HSBC Holdings first reported a position in DVAX in Q3 2019 and held it in 13 quarters. The position peaked at $725K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- HSBC Holdings reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- HSBC Holdings sold 47,132 Dynavax Technologies shares in Q1 2026, an estimated $725K.
- HSBC Holdings first reported a position in Dynavax Technologies in Q3 2019 and held it in 13 quarters.
- HSBC Holdings's Dynavax Technologies position peaked at $725K in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.